Since the onslaught of publicity surrounding the French Paradox, the scientific community started in earnest to examine the potential extraordinary benefits of the compound resveratrol. The compound has been examined for its potential effect on heart disease, cancer, other age-related ailments, obesity, longevity and more. But most tests have been done in vitro (in a test tube) or in mice, not in humans. Although many researchers feel optimistic about the potential significant benefits of resveratrol, much more work needs to happen, including human studies. Most of the positive test results have yet to be replicated in humans.
Clinicaltrials.gov, a service of the U.S. National Institutes of Health indicates that recruiting is underway for resveratrol studies involving for the following conditions as of November 6, 2008:
- colon cancer
- colorectal cancer
- follicular lymphoma
This link is to clinica/trials.gov for an updated list of resveratrol trials